Browsing Category

38982 posts
HKeyBio Launches HKEY-NHP-onChip™ 1.1: World's First NHP In Vitro Model for Autoimmune and Allergic Diseases

HKeyBio Launches HKEY-NHP-onChip™ 1.1: World's First NHP In Vitro Model for Autoimmune and Allergic Diseases

The integrated organ-on-chip platform offers 10–100x cost efficiency and 80% reduction in animal use, bridging the gap between preclinical NHP research and human clinical success. SUZHOU, China, SAN FRANCISCO and BOSTON, March 24, 2026 /PRNewswire/ —…

X Square Robot and Global Partners Launch ManipArena at CVPR 2026

The launch sets a new global benchmark for evaluating real-world embodied intelligence…

Erayak Power Solution Strategic Update: Accelerating High-Capacity UPS-Integrated Platforms to Support AI-Driven Energy Demand

Prototype preview expected at the 2026 National Hardware Show as Ruike Electronics…

Dynacast Expands Integrated Manufacturing Capabilities with Addition of Platinadora Baja

CHARLOTTE, N.C., March 24, 2026 /PRNewswire/ — Form Technologies, the parent company…
Rain Expands Visa Membership Into Asia-Pacific, Advancing the Reach of Its Global Stablecoin Payment Infrastructure

Rain Expands Visa Membership Into Asia-Pacific, Advancing the Reach of Its Global Stablecoin Payment Infrastructure

Rain’s expanded issuing footprint enables global consumer and corporate credit card programs…
SPESYN Launches ST3 on Kickstarter, Bringing Drill-Press Precision to a Handheld Power Tool

SPESYN Launches ST3 on Kickstarter, Bringing Drill-Press Precision to a Handheld Power Tool

Empowered by 90° alignment, real-time depth sensing with 0.1 mm accuracy, and…

Agero Receives Frost & Sullivan's 2025 North American Digitalized Roadside Assistance Services Company of the Year Recognition for Market Leadership Excellence

The company is honored for redefining industrial performance through GenAI copilots, automation,…

Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study

Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study…